Kochi : Abbott, the global healthcare leader, announced the launch of its digital health tool, FreeStyle LibreLink app in India. The mobile application will allow people who use the FreeStyle Libre system to measure their glucose to now get their readings on their mobile phones anytime, anywhere without the pain of pricking.1 By launching an integrated FreeStyle Libre digital platform, Abbott aims to empower people to better manage their diabetes through easy monitoring, easy insights and easy connection. The mobile app is available to work on compatible iPhone and Android smartphones.
The FreeStyle LibreLink app enables people with diabetes to see their glucose data in real-time on their smartphones, and easily share the information with their doctors and caregivers. The mobile app uses near-field communication (NFC) technology to transfer glucose data from the sensor to the mobile app, allowing people to help track eight-hour glucose history, real-time trend patterns to manage food, insulin use, medication and exercise on their smartphone. This eliminates the need to use a separate reader for glucose monitoring.
Speaking on the launch, Kalyan Sattaru, general manager of Abbott’s Diabetes Care Business in South Asia said, “People living with diabetes experience significant burden as they face multitude of tasks to effectively manage their diabetes. FreeStyle LibreLink app seamlessly integrates with FreeStyle Libre sensor, the world’s No.1 continuous glucose monitoring (CGM) used by more than 5 million people with diabetes globally.2 At Abbott, we are committed to ensuring our FreeStyle Libre technology not only simplifies the daily routines for people living with diabetes, but also empowers them to manage their diabetes more effectively.”
